Taligen Therapeutics - Ownership and Business Overview

Life ScienceCompany

Taligen Therapeutics Ownership

Who owns Taligen Therapeutics?

Taligen Therapeutics is owned by Alexion Pharmaceuticals. It was acquired on January 31, 2011.

Was Taligen Therapeutics formerly PE-backed?

Yes. Taligen Therapeutics was formerly owned by 1 private investor.

Taligen Therapeutics Business Overview

Where is Taligen Therapeutics headquartered?

Taligen Therapeutics is headquartered in Cambridge, Massachusetts.

What sector is Taligen Therapeutics in?

Taligen Therapeutics is a life science company.

When was Taligen Therapeutics founded?

Taligen Therapeutics was founded in 2004.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 171 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 148 by strategics.

Taligen Therapeutics, Inc.

245 First Street 18th Floor Suite 1830,
Cambridge, Massachusetts 02142
United States,
617-444-8443
www.taligentherapeutics.com

Taligen is a development stage biotechnology company focused on the treatment of serious inflammatory diseases including asthma, macular degeneration and immune kidney disease.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.